Filter News
Area of Research
- (-) Materials (14)
- (-) Neutron Science (14)
- (-) Nuclear Science and Technology (13)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (21)
- Clean Energy (21)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (10)
- Fusion Energy (7)
- Isotopes (6)
- Materials for Computing (3)
- National Security (12)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Sensors and Controls (1)
- Supercomputing (23)
News Topics
- (-) Advanced Reactors (14)
- (-) Biomedical (18)
- (-) Net Zero (1)
- (-) Renewable Energy (1)
- (-) Security (3)
- 3-D Printing/Advanced Manufacturing (30)
- Artificial Intelligence (12)
- Big Data (3)
- Bioenergy (16)
- Biology (9)
- Biotechnology (1)
- Buildings (5)
- Chemical Sciences (33)
- Clean Water (4)
- Climate Change (5)
- Composites (9)
- Computer Science (26)
- Coronavirus (12)
- Critical Materials (13)
- Cybersecurity (6)
- Decarbonization (10)
- Energy Storage (38)
- Environment (21)
- Exascale Computing (2)
- Fossil Energy (1)
- Frontier (4)
- Fusion (16)
- Grid (5)
- High-Performance Computing (6)
- Irradiation (1)
- Isotopes (16)
- ITER (1)
- Machine Learning (7)
- Materials (80)
- Materials Science (88)
- Mathematics (1)
- Microscopy (27)
- Molten Salt (7)
- Nanotechnology (43)
- National Security (4)
- Neutron Science (108)
- Nuclear Energy (50)
- Partnerships (11)
- Physics (32)
- Polymers (18)
- Quantum Computing (4)
- Quantum Science (15)
- Simulation (1)
- Space Exploration (10)
- Summit (6)
- Sustainable Energy (15)
- Transformational Challenge Reactor (5)
- Transportation (19)
Media Contacts
How do you get water to float in midair? With a WAND2, of course. But it’s hardly magic. In fact, it’s a scientific device used by scientists to study matter.
Anne Campbell, a researcher at ORNL, recently won the Young Leaders Professional Development Award from the Minerals, Metals & Materials Society, or TMS, and has been chosen as the first recipient of the Young Leaders International Scholar Program award from TMS and the Korean Institute of Metals and Materials, or KIM.
ORNL has been selected to lead an Energy Earthshot Research Center, or EERC, focused on developing chemical processes that use sustainable methods instead of burning fossil fuels to radically reduce industrial greenhouse gas emissions to stem climate change and limit the crisis of a rapidly warming planet.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
An innovative and sustainable chemistry developed at ORNL for capturing carbon dioxide has been licensed to Holocene, a Knoxville-based startup focused on designing and building plants that remove carbon dioxide
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.